Response to DDAVP stimulation in thirteen patients with Buerger's disease.
Siguret
V
V
INSERM U 428, Hôpital Broussais, Paris, France.
Alhenc-Gelas
M
M
Aiach
M
M
Fiessinger
J N
JN
Gaussem
P
P
D000328:Adult; D016022:Case-Control Studies; D003894:Deamino Arginine Vasopressin; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D013919:Thromboangiitis Obliterans / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000097:blood
D005338:Fibrin Fibrinogen Degradation Products; D017395:Plasminogen Activator Inhibitor 1; D010959:Tissue Plasminogen Activator; D003894:Deamino Arginine Vasopressin